Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.

MLA

Wortmann, Lars, et al. “Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.” Journal of Medicinal Chemistry, vol. 64, no. 21, Nov. 2021, pp. 15883–911. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.1c01245.

APA

Wortmann, L., Bräuer, N., Holton, S. J., Irlbacher, H., Weiske, J., Lechner, C., Meier, R., Karén, J., Siöberg, C. B., Pütter, V., Christ, C. D., Laak, A. ter, Lienau, P., Lesche, R., Nicke, B., Shing-Hu Cheung, Bauser, M., Haegebarth, A., von Nussbaum, F., & Mumberg, D. (2021). Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A. Journal of Medicinal Chemistry, 64(21), 15883–15911. https://doi.org/10.1021/acs.jmedchem.1c01245

Chicago

Wortmann, Lars, Nico Bräuer, Simon J. Holton, Horst Irlbacher, Jörg Weiske, Christian Lechner, Robin Meier, et al. 2021. “Discovery and Characterization of the Potent and Highly Selective 1,7-Naphthyridine-Based Inhibitors BAY-091 and BAY-297 of the Kinase PIP4K2A.” Journal of Medicinal Chemistry 64 (21): 15883–911. doi:10.1021/acs.jmedchem.1c01245.